Top compounds associated with response to RPL9


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.091 0.007
mRNA QL-X-138 GDSC1000 pan-cancer AAC 0.09 0.007
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.098 0.007
mRNA Y-39983 GDSC1000 pan-cancer AAC 0.094 0.007
mRNA CD-437 CTRPv2 pan-cancer AAC 0.095 0.008
mRNA AT-7519 GDSC1000 pan-cancer AAC 0.085 0.008
mRNA GSK2126458 GDSC1000 pan-cancer AAC 0.091 0.008
mRNA GSK461364 CTRPv2 pan-cancer AAC 0.093 0.009
mRNA tivozanib CTRPv2 pan-cancer AAC 0.11 0.009
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.095 0.009
Download CSV